Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04482673 · ClinicalTrials.gov registry record · Phase 4

Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection

A Phase 4 study of COVID-19 and Vitamin D Deficiency, sponsored by Medical University of South Carolina.

Active
Registry status
Phase 4
Development phase
95
Enrollment target
1
Study location

NCT04482673 is a Phase 4 study of COVID-19 and Vitamin D Deficiency that is active but no longer recruiting, run by Medical University of South Carolina. The registered enrollment target is 95 participants, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04482673, a Phase 4 study of COVID-19 and Vitamin D Deficiency, is active but no longer recruiting, sponsored by Medical University of South Carolina.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
95 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate how useful vitamin D supplementation is in reducing the severity of COVID-19 symptoms and the body's inflammatory and infection-fighting response to COVID-19. Individuals ≥50 years of age and older who are tested for COVID-19 and negative will be randomized (like flipping a coin) to either daily high dose vitamin D supplementation (6000 IU vitamin D3/day) vs. standard of care. Those individuals ≥50 years of age or older who test positive for COVID-19 at baseline will be randomized to bolus vitamin D (20,000 IU/day for 3 days) followed by high dose (6000 IU vitamin D/day) vs. standard of care for 12 months. All participants will receive a multivitamin containing vitamin D.

Conditions Studied

COVID-19 Vitamin D Deficiency Respiratory Viral Infection

Interventions

  • DRUG Daily Vitamin D3
  • DRUG Daily placebo
  • DRUG Bolus vitamin D3
  • DRUG Bolus placebo

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2020-07-31
Est. Completion 2023-12-31
Phase Phase 4

Sponsor

Medical University of South Carolina

755 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04482673

The ClinicalTrials.gov registry entry for NCT04482673 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with COVID-19 appearing as the primary indexed condition, and to 4 interventions - of which Daily Vitamin D3 is the first listed.

NCT04482673 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT04482673 about?

NCT04482673 is a clinical study titled "Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection". The purpose of this study is to evaluate how useful vitamin D supplementation is in reducing the severity of COVID-19 symptoms and the body's inflammatory and infection-fighting response to COVID-19. Individuals ≥50 years of age and older who are tested for COVID-19 and negative will be randomized (...

What is the current status of trial NCT04482673?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 95 participants. The study started on 2020-07-31. Estimated completion is 2023-12-31.

What conditions does trial NCT04482673 study?

This clinical trial studies the following conditions: COVID-19, Vitamin D Deficiency, Respiratory Viral Infection.

What interventions are being tested in trial NCT04482673?

The interventions under investigation include: Daily Vitamin D3 (DRUG), Daily placebo (DRUG), Bolus vitamin D3 (DRUG), Bolus placebo (DRUG).

Who is sponsoring clinical trial NCT04482673?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04482673 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

COVID-19

All registered trials for this condition

Vitamin D Deficiency

All registered trials for this condition

South Carolina

All trials with a study site in South Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.